A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

Investigational Site Number : 0320016, Buenos Aires

Investigational Site Number : 0320001, Buenos Aires

Investigational Site Number : 0320002, Buenos Aires

Investigational Site Number : 0320009, Buenos Aires

Investigational Site Number : 1002005, Sofia

Investigational Site Number : 7100004, Boksburg

Investigational Site Number : 7100015, Johannesburg

Investigational Site Number : 0320017, Pilar

Investigational Site Number : 0320021, Berazategui

Investigational Site Number : 0320006, Rosario

Investigational Site Number : 0320007, Rosario

Investigational Site Number : 0320015, Rosario

Investigational Site Number : 7100007, Johannesburg

Investigational Site Number : 2080003, Herlev

Investigational Site Number : 7100012, Durban

Investigational Site Number : 7100001, Durban

Investigational Site Number : 1002008, Gabrovo

Investigational Site Number : 1002004, Pleven

Investigational Site Number : 7100010, Cape Town

Investigational Site Number : 7100009, Cape Town

Investigational Site Number : 2080001, Aarhus

Investigational Site Number : 2080002, Aalborg

Equity Medical- Site Number : 8401239, New York

Montefiore Medical Center - Moses Campus- Site Number : 8401150, The Bronx

OmeraNY- Site Number : 8401156, Brooklyn

PEAK Research- Site Number : 8401083, Upper Saint Clair

Investigational Site Number : 7240018, Granada

Dermatology Associates of Plymouth Meeting- Site Number : 8401147, Plymouth Meeting

Investigational Site Number : 3800018, Rozzano

Investigational Site Number : 4840012, Aguascalientes

Care Access Research - Marriottsville- Site Number : 8401126, Marriottsville

Care Access - Arlington- Site Number : 8401134, Arlington

Velocity Clinical Research - Hampton- Site Number : 8401154, Hampton

Investigational Site Number : 7240029, Madrid

Investigational Site Number : 7242503, Madrid

Columbia Dermatology & Aesthetics- Site Number : 8401166, Columbia

First Georgia Physician Group- Site Number : 8401190, Fayetteville

AllerVie Clinical Research - Columbus- Site Number : 8401104, Columbus

Accel Research - Nona Pediatric Center- Site Number : 8401081, Orlando

Skin Care Research - Hollywood- Site Number : 8401071, Hollywood

Nuline Clinical Trial Center- Site Number : 8401161, Pompano Beach

Savin Medical Group - Miami- Site Number : 8401085, Miami

Pediatric Skin Research- Site Number : 8401198, Coral Gables

Anchor Medical Research- Site Number : 8401300, Miami

Investigational Site Number : 7920011, Mersin

Clinical Research Trials of Florida- Site Number : 8401023, Tampa

Investigational Site Number : 4840009, Durango

Investigational Site Number : 7920005, Istanbul

Investigational Site Number : 7920006, Istanbul

Investigational Site Number : 7920002, Istanbul

Investigational Site Number : 7240012, Las Palmas de Gran Canaria

Investigational Site Number : 3800022, Vicenza

Investigational Site Number : 7920004, Kayseri

University Of Mississippi Medical Center- Site Number : 8401184, Jackson

Access Dermatology- Site Number : 8401296, Bowling Green

Bexley Dermatology Research- Site Number : 8401051, Bexley

Velocity Clinical Research - Springdale- Site Number : 8401153, Cincinnati

Investigational Site Number : 7920007, Samsun

Investigational Site Number : 3800008, Pisa

Health Concepts- Site Number : 8401059, Rapid City

Red River Research Partners- Site Number : 8401196, Fargo

Investigational Site Number : 4840011, Monterrey

Investigational Site Number : 4840005, Monterrey

MedPharmics - Covington- Site Number : 8401137, Covington

Derm Texas- Site Number : 8401217, Dallas

Arlington Research Center- Site Number : 8401248, Arlington

Center for Clinical Studies - Houston - Binz Street- Site Number : 8401063, Houston

Prolato Clinical Research Center- Site Number : 8401209, Houston

Sienna Dermatology- Site Number : 8401148, Missouri City

Progressive Clinical Research - San Antonio- Site Number : 8401016, San Antonio

Advanced Research Institute - Odgen- Site Number : 8401057, Ogden

Center for Dermatology and Plastic Surgery- Site Number : 8401119, Scottsdale

Eclipse Clinical Research- Site Number : 8401158, Tucson

University of New Mexico Comprehensive Cancer Center- Site Number : 8401263, Albuquerque

Dermatology Research Associates - Los Angeles- Site Number : 8401092, Los Angeles

Clinical Science Institute- Site Number : 8401028, Santa Monica

Torrance Clinical Research- Site Number : 8401027, Lomita

Investigational Site Number : 4840003, Veracruz

Allergy & Asthma Associates of Southern California - Mission Viejo- Site Number : 8401079, Mission Viejo

Cura Clinical Research - Oxnard- Site Number : 8401142, Oxnard

Investigational Site Number : 3800009, Catania

Investigational Site Number : 1560004, Beijing

Investigational Site Number : 1560030, Beijing

Investigational Site Number : 1560026, Shenyang

Investigational Site Number : 1560001, Shanghai

Investigational Site Number : 1560005, Shanghai

Investigational Site Number : 1560028, Zhenjiang

Investigational Site Number : 1560003, Wuxi

Investigational Site Number : 1560007, Jinan

Investigational Site Number : 1560002, Hangzhou

Investigational Site Number : 1560006, Hangzhou

Investigational Site Number : 1560029, Hangzhou

Investigational Site Number : 1560024, Ningbo

Investigational Site Number : 1560023, Wenzhou

Investigational Site Number : 1560021, Guangzhou

Investigational Site Number : 1560025, Guangzhou

Investigational Site Number : 1560022, Chengdu

Investigational Site Number : 1520015, Quillota

Investigational Site Number : 1520004, Valdivia

Investigational Site Number : 1520013, Santiago

Investigational Site Number : 1520003, Santiago

Investigational Site Number : 1520014, Santiago

University of Connecticut Health Center- Site Number : 8401115, Farmington

Tufts Medical Center Site Number : 8401201, Boston

Care Access - Hoboken- Site Number : 8401132, Hoboken

Investigational Site Number : 2032106, Kutná Hora

Investigational Site Number : 2030010, Olomouc

Investigational Site Number : 2032104, Ostrava

Investigational Site Number : 2030011, Prague

Investigational Site Number : 2030006, Prague

Investigational Site Number : 3800013, Rome

Investigational Site Number : 3920009, Chitose

Investigational Site Number : 3923114, Obihiro

Investigational Site Number : 3920008, Sapporo

Investigational Site Number : 3920006, Kobe

Investigational Site Number : 3920005, Sagamihara

Investigational Site Number : 3923113, Yokohama

Investigational Site Number : 3920010, Miyagi-gun

Investigational Site Number : 3920011, Sendai

Investigational Site Number : 3923109, Habikino

Investigational Site Number : 3923110, Sakai

Investigational Site Number : 3920002, Iruma

Investigational Site Number : 3923106, Mibu

Investigational Site Number : 3920004, Chūō

Investigational Site Number : 3923107, Minato

Investigational Site Number : 3920001, Tachikawa

Investigational Site Number : 3923108, Kagoshima

Investigational Site Number : 3923102, Kyoto

Investigational Site Number : 3920003, Kyoto

Investigational Site Number : 6200005, Lisbon

Investigational Site Number : 6200004, Lisbon

Investigational Site Number : 6200001, Lisbon

Investigational Site Number : 6200003, Porto

Investigational Site Number : 7100003, Pretoria

Investigational Site Number : 7520006, Älvsjö

Investigational Site Number : 7520001, Örebro

Investigational Site Number : 7920001, Antalya

Investigational Site Number : 8260003, Portsmouth

Investigational Site Number : 8262602, London

Investigational Site Number : 8262601, London

Investigational Site Number : 8260006, Glasgow

Investigational Site Number : 8260004, Leicester